Caricamento...
Development of Immunotherapy Combination Strategies in Cancer
Harnessing the immune system to treat cancer through inhibitors of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) and Programmed Death Ligand-1 (PD-L1) has revolutionalized the landscape of cancer. Rational combination strategies aim to enhance the antitumor effects of immunotherapies, but require a deep...
Salvato in:
| Pubblicato in: | Cancer Discov |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178168/ https://ncbi.nlm.nih.gov/pubmed/33811048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-1209 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|